Rockefeller Capital Management L.P. Increases Position in HCA Healthcare, Inc. $HCA

Rockefeller Capital Management L.P. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 17.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,957 shares of the company’s stock after purchasing an additional 2,876 shares during the period. Rockefeller Capital Management L.P.’s holdings in HCA Healthcare were worth $8,850,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of HCA. Norges Bank purchased a new stake in HCA Healthcare in the 4th quarter worth $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in shares of HCA Healthcare in the fourth quarter worth about $374,037,000. Viking Global Investors LP increased its stake in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares in the last quarter. Finally, Danske Bank A S bought a new position in HCA Healthcare during the third quarter valued at $115,530,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $387.14 on Friday. The stock has a 50 day moving average price of $410.50 and a 200 day moving average price of $465.84. The firm has a market capitalization of $85.88 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analysts Set New Price Targets

HCA has been the subject of a number of analyst reports. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Barclays lowered their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Robert W. Baird dropped their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $503.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.